Financials
- Market Capitalization 519.81 M
- Employee 2 842
- Founded 2013
- CEO Irwin D.Simon
- Website www.tilray.com
- Headquarter New York, United States
- FIGI BBG00L7XTP60
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.17
ratio cours/chiffre d'affaires
0.44
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2602 | ESPR Esperion Therapeutics, Inc. - Common Stock | 3.18 USD | 0.00% | +0.63% | +0.63% | +169.49% | 818.63 M USD | ||
| 2703 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.21 USD | -5.82% | -6.03% | +11.67% | +468.92% | 693.02 M USD | ||
| 2911 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.06 USD | -1.46% | -5.80% | -3.56% | +0.50% | 509.33 M USD | ||
| 3034 | EOLS Evolus, Inc. - Common Stock | 6.52 USD | -1.36% | -6.99% | -3.55% | -32.08% | 429.37 M USD |